Pros
Respected as the "Grandaddy" of hereditary cancer genetic laboratories. Products are top quality in any niche. Training is excellent. Work / Life balance was valued. Incentives and commissions can be significant.
Cons
Salaries continue to be substandard compared to other oncology opportunities. High level performers can compensate with generous bonuses to some degree. The novelty is gone and competition is high since 2013 Supreme Court decision on BRCA testing. Some providers feel hostility toward Myriad for their handling of genetic counselors as part of the process and their unwillingness to open their data bank. This can inhibit sales but regardless, as an entry to diagnostics I would do it all over again. It's a good company.
